Literature DB >> 3971300

Colon carcinoma in children and adolescents. A review of 30 cases.

B N Rao, C B Pratt, I D Fleming, R A Dilawari, A A Green, B A Austin.   

Abstract

Carcinoma of the large bowel is rare in persons under the age of 30, and generally presents with advanced stages of disease. From 1964 to 1984, 30 patients presented with nonfamilial large bowel malignancies. Seventeen patients were male, and 13 female (age range, 8-25 years). In 15 patients the primary was in the right transverse colon. In 26 patients the lesion was above the peritoneal reflection. Classification by Dukes' staging demonstrated Stage B in 3 patients, Stage C in 7 patients, and Stage D in 20 patients. Twenty-five patients had a mucinous variety of adenocarcinoma. Surgery at initial laparotomy consisted of biopsy (10 patients), palliative segmental resection (7 patients) and complete resection (13 patients; survival in each of these groups ranged from 1 to 15 months (median, 6 months), 6 to 36 months (median, 8 months) and 7 months to 14 years (median, 6 months), respectively. The only long-term survivors are three patients who had complete resection, two of whom are surviving free of disease after 5 and 15 years, respectively. Common sites of abdominal recurrence were the omentum (6 patients) and ovaries (7 patients). All patients received chemotherapy. In 16 of 24 evaluable patients, responses lasting 3 to 18 months were observed. Five patients also received radiation therapy. Follow-up of these patients included computed tomographic scans, ultrasound, and determination of carcinoembryonic antigen (CEA) levels. The CEA level in 9 of 23 patients did not correspond with the presence of either residual disease or progression of disease. Chemotherapy combined with a second-look surgical procedure in selected cases may improve the proportion of patients surviving and the duration of survival.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3971300     DOI: 10.1002/1097-0142(19850315)55:6<1322::aid-cncr2820550627>3.0.co;2-5

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  28 in total

1.  Advanced colonic carcinoma in children.

Authors:  A M Khan; C M Doig; A P Dickson
Journal:  Postgrad Med J       Date:  1997-03       Impact factor: 2.401

2.  Redundant colon and carcinoma of the right colon.

Authors:  E Perry-Thornton; J Karkala; G P Verly; M Walker
Journal:  J Natl Med Assoc       Date:  1989-06       Impact factor: 1.798

3.  Carcinoma of the colon: diagnosis by ultrasound and enema.

Authors:  B J Cremin; R A Brown
Journal:  Pediatr Radiol       Date:  1987

4.  Colorectal carcinoma.

Authors:  S Kothari; G Prabhakar; V B Kalra
Journal:  Indian J Pediatr       Date:  1998 Nov-Dec       Impact factor: 1.967

5.  Abdominal pain, diarrhea, constipation--which symptom is more indispensable to have a colonoscopy?

Authors:  Jia Cai; Zhe Yuan; Shujun Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

6.  Carcinoma of the rectum in children.

Authors:  S P Sahoo; A N Gangopadhyay; D K Gupta; S C Gopal; C K Sinha; S Gupta; M Kumar
Journal:  Pediatr Surg Int       Date:  2013-09-21       Impact factor: 1.827

7.  Colorectal cancer with neuroendocrine differentiation in a child.

Authors:  Carlo Angelini; Stefano Crippa; Fabio Uggeri; Claudia Bonardi; Paola Sartori; Franco Uggeri
Journal:  Pediatr Surg Int       Date:  2005-10-21       Impact factor: 1.827

Review 8.  Colorectal adenocarcinoma in childhood and adolescent. Report of 11 cases and review of the literature.

Authors:  C M Lamego; H Torloni
Journal:  Pediatr Radiol       Date:  1989

Review 9.  Epidemiology and management options for colorectal cancer in children.

Authors:  Raya Saab; Wayne L Furman
Journal:  Paediatr Drugs       Date:  2008       Impact factor: 3.022

10.  Fifteen-year-old colon cancer patient with a 10-year history of ulcerative colitis.

Authors:  Seung Yeon Noh; Seung Young Oh; Soo-Hong Kim; Hyun-Young Kim; Sung-Eun Jung; Kwi-Won Park
Journal:  World J Gastroenterol       Date:  2013-04-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.